Electrolysis Valve for Intraocular Pressure Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current glaucoma treatments, such as drainage devices, lack smart and interactive control over fluid flow, leading to increased flow resistance due to fibrosis at the drainage site, which reduces their effectiveness in managing intraocular pressure (IOP).

Innovation Solution

An IOP control system with a drainage tube and a valve system that uses electrolysis to control fluid flow, incorporating sensors to detect pressures in the anterior chamber, atmospheric pressure, and the drainage site, and a processor to adjust the valve system based on these readings to maintain desired pressures.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If a passive drainage device is implanted to relieve IOP, then fluid drainage is achieved, but flow resistance increases over time due to fibrosis at the drainage site

Engineering Contradiction:
Improvedrainage effectivenessVSAvoidfluid flow rate
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent implements an active valve system that dynamically adjusts the drainage opening area based on real-time pressure feedback from sensors. The valve can change its flow characteristics in response to varying fibrosis conditions, maintaining optimal fluid flow rates even as tissue resistance changes over time. This dynamic adjustment capability allows the system to adapt to progressive fibrosis without requiring surgical intervention.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The system incorporates pressure sensors that continuously monitor IOP and drainage site pressure, feeding this information to a control algorithm. Based on the pressure differential and detected fibrosis resistance, the control system adjusts the valve opening to maintain target IOP levels. This closed-loop feedback mechanism compensates for increasing flow resistance caused by fibrosis, preserving drainage effectiveness throughout the device's lifespan.

Inventive Principle:
Principle #23Feedback

2Reliability

If a drainage device is implanted to lower IOP, then pressure relief is achieved, but the device lacks smart control over fluid flow

Engineering Contradiction:
ImproveIOP managementVSAvoidflow control capability
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent implements a self-regulating system where the valve automatically adjusts its opening based on real-time pressure feedback from implanted sensors. The control algorithm processes pressure differential data and autonomously modulates the valve to maintain target IOP levels without requiring external intervention. This self-service capability enables smart, adaptive IOP management that responds dynamically to changing physiological conditions.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The system replaces passive mechanical drainage with an active electro-mechanical valve system controlled by electronic sensors and a power source. The valve uses electrical actuation (such as shape memory alloys or electromagnetic actuators) to adjust opening area based on electronic control signals, transitioning from a purely mechanical passive device to an intelligent system with sensor-actuator integration.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Reliability

If fibrosis develops at the drainage site, then flow resistance increases, but the system should maintain drainage effectiveness

Engineering Contradiction:
Improvedrainage functionVSAvoidflow resistance
Core Design Contradiction:
ReliabilityVSStress or pressure

Solution Approach 1:

The valve system dynamically adjusts its opening area in response to detected changes in flow resistance. As fibrosis develops and resistance increases, the control algorithm increases the valve opening to compensate, maintaining adequate fluid flow rates. This dynamic adaptation allows the system to overcome progressive fibrosis without losing drainage effectiveness.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The system changes the valve opening parameter (area) in response to detected fibrosis-induced resistance changes. By monitoring pressure differential and flow characteristics, the control system adjusts the valve opening size to optimize flow despite increasing resistance from tissue fibrosis, maintaining drainage function throughout the device's operational life.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system effectively regulates IOP and bleb pressure, reducing fibrosis and improving the longevity and effectiveness of glaucoma treatments by actively managing fluid flow and pressure differentials.

Implementation Method 1

The valve system may be configured to control fluid flow using an electrolysis process

Methodology Applied
Scientific EffectElectrolysis: Electrolysis

Data Source

PatentUS8753305B2Bubble-driven IOP control system
Publication Date: 2014.06.17 ALCON INC
  • US8753305B2 patent drawing
  • US8753305B2 patent drawing
  • US8753305B2 patent drawing

AI summary

An intraocular pressure control system for implantation in an eye of a patient to provide drainage from an anterior chamber of the eye to a drainage location at the eye includes a drainage tube and a valve system arranged to control drainage flow between the anterior chamber and the drainage site, the valve system being configured to control fluid flow using an electrolysis process and closed loop feedback from pressure sensors able to determine: flow rate, IOP, bleb pressure, and internal valve pressure.